Ultrasound in the management of pleural disease

ABSTRACT

Introduction: Pleural disease encompasses a large range of conditions, is a common presentation to the acute medical take and often requires comprehensive investigation and treatment. Ultrasound is well recognised as a useful investigative tool in pleural disease especially in the field of pleural effusion, pleural thickening and interventional procedures. Thoracic ultrasound (TUS) has gained widespread use by physicians as evidence has shown a reduced rate of complications when performing pleural procedures with ultrasound guidance.

Areas covered: This article will review studies assessing the role of TUS in the management of pleural disease and examine ongoing research into how TUS could advance our knowledge and understanding over the next decade.

Expert commentary: Physician lead thoracic ultrasound has become commonplace over the last decade, and now represents a minimum standard of safety in conducting the majority of ‘bedside’ pleural procedures. The current evidence points to important diagnostic and procedural roles of the use of bedside thoracic ultrasound. In the future, research developments are likely to lead to the use of thoracic ultrasound in prognostication, targeted treatment and understanding pathogenesis in pleural disease.

KEYWORDS:

• Ultrasound
• pleural
• effusion
• pneumothorax
• malignant

Declaration of interest

NM. Rahman is supported by the NIHR Oxford Biomedical Research Centre. I. Psallidas is the recipient of a RESPIRE2 European Respiratory Society Fellowship (RESPIRE2-2015-7160). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Supplemental data for this article can be accessed here

Additional information

Funding

No external funding was sought or required in relation to the production of this article.